Literature DB >> 16935446

Phenytoin desensitization in a child with symptomatic localization-related epilepsy.

Seiko Itomi1, Akihisa Okumura, Taketo Ikuta, Tamiko Negoro, Kazuyoshi Watanabe.   

Abstract

We reported a child with refractory partial seizures successfully managed by clinical desensitization to phenytoin. The patient had ischemic brain lesions due to cardiopulmonary arrest at 39 weeks of corrected age. He had complex partial seizures refractory to several antiepileptic drugs since 4 years of age. At 8 years 1 month of age, phenytoin was first administered. Fever and maculopapular rashes appeared at 10 days after phenytoin initiation, and then the drug was discontinued. At 8 years 8 months of age, desensitization was attempted because of refractoriness of seizures to drugs other than phenytoin. Desensitization was started at 1mg daily, and then the dose was doubled every week. His seizures were controlled by 150mg/day of phenytoin in combination with primidone. No problems have been observed during desensitization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935446     DOI: 10.1016/j.braindev.2006.07.001

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  3 in total

Review 1.  Management of multiple drug allergies in children.

Authors:  Anahita Falakshahi Dioun
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

2.  Desensitization to Oxcarbazepine: Long-Term Efficacy and Tolerability.

Authors:  Jiwon Lee; Eu Gene Park; Munhyang Lee; Jeehun Lee
Journal:  J Clin Neurol       Date:  2016-10-07       Impact factor: 3.077

3.  A new rapid titration protocol for lamotrigine that reduces the risk of skin rash.

Authors:  Yoonhyuk Jang; Jangsup Moon; Narae Kim; Tae-Joon Kim; Jin-Sun Jun; Yong-Won Shin; Hyeyeon Chang; Hye-Ryun Kang; Soon-Tae Lee; Keun-Hwa Jung; Kyung-Il Park; Ki-Young Jung; Kon Chu; Sang Kun Lee
Journal:  Epilepsia Open       Date:  2021-05-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.